- Faculdade Ciências Médicas de Minas Gerais, Pós Graduação - Belo Horizonte - MG - Brasil.
Rev Col Bras Cir. 2023 Jul 10;50:e20233367. doi: 10.1590/0100-6991e-20233367-en. eCollection 2023.
the present study aims to evaluate cancer patients related to the catheter flow and the general satisfaction of these patients.
we studied 233 individuals diagnosed with cancer who underwent chemotherapy treatment through venous access through portocath between January 2015 and December 2019.
97% of the patients consulted had palliative chemotherapy, and 99.1% of patients reported satisfaction with the implantation process and treatment method. Regarding catheter flow according to venous return and drip during drug infusion, 98.7% of individuals presented good flow.
the results show that catheter flow was satisfactory in all implant sites observed and emphasize the advantages of using a totally implanted catheter. This benefice happens due to the reduction of emotional factors that cause stress in cancer patients receiving chemotherapy, as well as the reduction of trauma and discomfort experienced by patients during the infusion of peripheral chemotherapy.
本研究旨在评估癌症患者与导管流量以及这些患者的总体满意度相关的问题。
我们研究了 233 名在 2015 年 1 月至 2019 年 12 月期间通过 portocath 进行静脉通路化疗治疗的癌症患者。
97%接受咨询的患者接受姑息性化疗，99.1%的患者对植入过程和治疗方法表示满意。关于导管流量，根据静脉回流和药物输注过程中的滴注情况，98.7%的患者流量良好。
结果表明，在所有观察到的植入部位，导管流量均令人满意，并强调了使用完全植入式导管的优势。这一好处是由于减少了化疗癌症患者因情绪因素而产生的压力，以及减少了患者在接受外周化疗输注时所经历的创伤和不适。
